Rocket Lab Corporation filings document the public-company record for a launch services and space systems company whose common stock trades on Nasdaq under RKLB. Its 8-K reports disclose operating results, material agreements, acquisition activity, equity issuance matters, at-the-market and forward-sale arrangements, and other capital-structure events.
Proxy and governance filings cover annual meeting matters, stockholder proposals, director nomination procedures, executive compensation and stockholder voting items. The filing record also documents Rocket Lab’s common stock terms, liquidity disclosures tied to launch and space systems operations, and completed portfolio changes such as the Mynaric acquisition.
Rocket Lab director Edward H. Frank was granted 3,960 restricted stock units (RSUs) on 08/27/2025 under the company's non-employee director compensation policy and 2021 incentive plan. The RSUs carry a $0.0 purchase price and will vest in full on the earlier of the issuer's next annual meeting or the one-year anniversary of grant, provided Mr. Frank continues board service through that date. Following the grant, the filing shows Mr. Frank beneficially owns 150,004 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Alexander R. Slusky, a Rocket Lab Corp (RKLB) director, acquired 3,960 restricted stock units (RSUs) on 08/27/2025 under the company's non-employee director compensation and incentive plans. The RSUs vest in full on the earlier of the issuer's next annual meeting or one year from grant, subject to continuous board service. After the grant, the filing reports 123,849 shares held directly by Slusky and 534,675 shares held indirectly through Abalone Cove LLLP, of which he is the sole general partner and, with his spouse, a limited partner. The Form 4 was signed by an attorney-in-fact on Slusky's behalf.
Rocket Lab Corporation adopted a new Senior Executive Cash Incentive Bonus Plan that ties key executives’ cash bonuses to financial, operational, and individual performance goals set by the board’s Compensation Committee. Bonuses are determined each performance period and are generally paid only if the executive is still employed on the payment date.
The company also held its 2025 annual stockholder meeting. Stockholders elected three Class I directors for terms expiring at the 2028 meeting, ratified Deloitte & Touche LLP as auditor for 2025, and approved on an advisory basis the compensation of named executive officers. A proposed amendment to a subsidiary’s charter to remove a pass-through voting provision did not receive the required sixty-six and two‑thirds percent supermajority and therefore was not approved.
Rocket Lab Corporation announced the closing of its previously disclosed acquisition of the parent holding company of GEOST. The Company's wholly owned subsidiary completed the purchase by paying $125 million in cash and issuing 3,057,588 shares of common stock as part of the closing consideration. The purchase agreement also provides for a potential additional earnout of up to $50 million in cash tied to future revenue targets of GEOST's business. The company filed a prospectus supplement to permit resale of the issued shares and furnished a press release and legal opinion as exhibits to the filing.
This filing reports the transaction terms and related disclosures but does not include pro forma financials or details on expected integration or financing sources.
Rocket Lab Corporation announced the closing of its previously disclosed acquisition of the parent holding company of GEOST. The Company's wholly owned subsidiary completed the purchase by paying $125 million in cash and issuing 3,057,588 shares of common stock as part of the closing consideration. The purchase agreement also provides for a potential additional earnout of up to $50 million in cash tied to future revenue targets of GEOST's business. The company filed a prospectus supplement to permit resale of the issued shares and furnished a press release and legal opinion as exhibits to the filing.
This filing reports the transaction terms and related disclosures but does not include pro forma financials or details on expected integration or financing sources.
Rocket Lab Corp. registered for resale up to 3,057,588 shares of common stock that it issued in a private placement as partial consideration for its acquisition of LightRidge Interco Solutions Holdings, the parent of GEOST, pursuant to a Stock Purchase Agreement dated May 22, 2025. The registration satisfies registration rights granted to the selling stockholder and enables that holder to resell the shares on Nasdaq, OTC markets or in private transactions.
The company will not receive any proceeds from sales by the selling stockholder and will pay registration expenses while the selling stockholder bears selling costs. Prior to this offering Rocket Lab had 482,413,301 shares outstanding and the shares covered by this supplement represented 0.63% of that total. The prospectus notes typical resale risks, including that such sales or the perception of sales could depress RKLB's market price; on August 11, 2025 the last reported Nasdaq sale price was $45.02 per share.
Rocket Lab Corp. registered for resale up to 3,057,588 shares of common stock that it issued in a private placement as partial consideration for its acquisition of LightRidge Interco Solutions Holdings, the parent of GEOST, pursuant to a Stock Purchase Agreement dated May 22, 2025. The registration satisfies registration rights granted to the selling stockholder and enables that holder to resell the shares on Nasdaq, OTC markets or in private transactions.
The company will not receive any proceeds from sales by the selling stockholder and will pay registration expenses while the selling stockholder bears selling costs. Prior to this offering Rocket Lab had 482,413,301 shares outstanding and the shares covered by this supplement represented 0.63% of that total. The prospectus notes typical resale risks, including that such sales or the perception of sales could depress RKLB's market price; on August 11, 2025 the last reported Nasdaq sale price was $45.02 per share.
Rocket Lab (RKLB) Q2-25 10-Q highlights:
- Revenue: $144.5 m, up 36% YoY; 1H-25 revenue $267.1 m (+34%). Launch Services delivered $46.6 m; Space Systems $97.9 m.
- Gross profit: $46.4 m, margin 32.1% (25.6% prior-year).
- OpEx: R&D $66.1 m (+66%), SG&A $39.9 m (+31%).
- Operating loss: –$59.6 m; Net loss: –$66.4 m, EPS –$0.13 (vs –$0.08).
- Liquidity: Cash $564.1 m; total cash + securities $749.3 m after $396.6 m ATM equity raise.
- Backlog: $995 m, 58% convertible to revenue within 12 months.
- Balance sheet: Assets $1.55 bn; convertible notes $355 m; Trinity term loan $72.1 m.
- Cash flow: OpCF –$77.5 m; capex $60.7 m; financing inflow $406 m.
- Share count: 479.4 m outstanding (8/4/25) following ATM issuance and preferred conversion.
Takeaway: Strong top-line growth and margin expansion underscore demand for Space Systems, but enlarged R&D spend widened losses. Fresh capital markedly extends runway for Neutron development, yet persistent cash burn and dilution temper the upside.
Rocket Lab (RKLB) Q2-25 10-Q highlights:
- Revenue: $144.5 m, up 36% YoY; 1H-25 revenue $267.1 m (+34%). Launch Services delivered $46.6 m; Space Systems $97.9 m.
- Gross profit: $46.4 m, margin 32.1% (25.6% prior-year).
- OpEx: R&D $66.1 m (+66%), SG&A $39.9 m (+31%).
- Operating loss: –$59.6 m; Net loss: –$66.4 m, EPS –$0.13 (vs –$0.08).
- Liquidity: Cash $564.1 m; total cash + securities $749.3 m after $396.6 m ATM equity raise.
- Backlog: $995 m, 58% convertible to revenue within 12 months.
- Balance sheet: Assets $1.55 bn; convertible notes $355 m; Trinity term loan $72.1 m.
- Cash flow: OpCF –$77.5 m; capex $60.7 m; financing inflow $406 m.
- Share count: 479.4 m outstanding (8/4/25) following ATM issuance and preferred conversion.
Takeaway: Strong top-line growth and margin expansion underscore demand for Space Systems, but enlarged R&D spend widened losses. Fresh capital markedly extends runway for Neutron development, yet persistent cash burn and dilution temper the upside.
Rocket Lab (RKLB) Q2-25 10-Q highlights:
- Revenue: $144.5 m, up 36% YoY; 1H-25 revenue $267.1 m (+34%). Launch Services delivered $46.6 m; Space Systems $97.9 m.
- Gross profit: $46.4 m, margin 32.1% (25.6% prior-year).
- OpEx: R&D $66.1 m (+66%), SG&A $39.9 m (+31%).
- Operating loss: –$59.6 m; Net loss: –$66.4 m, EPS –$0.13 (vs –$0.08).
- Liquidity: Cash $564.1 m; total cash + securities $749.3 m after $396.6 m ATM equity raise.
- Backlog: $995 m, 58% convertible to revenue within 12 months.
- Balance sheet: Assets $1.55 bn; convertible notes $355 m; Trinity term loan $72.1 m.
- Cash flow: OpCF –$77.5 m; capex $60.7 m; financing inflow $406 m.
- Share count: 479.4 m outstanding (8/4/25) following ATM issuance and preferred conversion.
Takeaway: Strong top-line growth and margin expansion underscore demand for Space Systems, but enlarged R&D spend widened losses. Fresh capital markedly extends runway for Neutron development, yet persistent cash burn and dilution temper the upside.